ProQR Therapeutics N.V.
PRQR
$1.99
$0.041.80%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -81.40% | -85.44% | -11.00% | 1.17% | 31.65% |
| Total Depreciation and Amortization | -2.49% | -1.55% | 2.48% | 9.90% | 13.23% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 448.10% | 213.98% | 173.92% | 205.25% | -160.10% |
| Change in Net Operating Assets | -11.55% | 47.18% | 16.68% | -127.34% | -125.48% |
| Cash from Operations | -53.33% | -23.44% | 4.93% | -272.57% | -440.61% |
| Capital Expenditure | 66.27% | 61.58% | 54.06% | -3.73% | -148.87% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -75.22% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -145.27% | 227.51% | 227.51% | -143.14% | -- |
| Cash from Investing | -183.39% | 203.65% | 202.23% | -189.90% | 651.75% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 40.57% | 39.68% | 46.87% | 39.83% | -54.39% |
| Issuance of Common Stock | 19,084.49% | 13,592.94% | 13,807.56% | 20,198.87% | -97.38% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3,174.19% | 3,438.93% | 2,937.96% | 3,145.25% | -119.03% |
| Foreign Exchange rate Adjustments | -170.48% | -2,188.81% | -84.68% | 8.58% | 63.45% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 149.61% | 180.31% | 186.90% | 25.49% | -255.76% |